Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.
about
Actions of estradiol on discrete attributes of the luteinizing hormone pulse signal in man. Studies in postmenopausal women treated with pure estradiol.Pituitary self-priming actions of gonadotropin-releasing hormone. Kinetics of estradiol's potentiating effects on gonadotropin-releasing hormone-facilitated luteinizing hormone and follicle-stimulating hormone release in healthy postmenopausal womenRole of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in manClinical use of aromatase inhibitors: current data and future perspectives.The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers.The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuumEffective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients.The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients.Long-term safety of aromatase inhibitors in the treatment of breast cancer.Aromatase inhibition 2013: clinical state of the art and questions that remain to be solvedAdditive endocrine therapy for advanced breast cancer - back to the future.Alterations in the pulsatile properties of gonadotropin secretion in alcoholic men.Adrenal of male dog secretes androgens and estrogens.
P2860
Q30449373-379DA014-0AD4-45E4-AC05-A4E8D0903051Q30449380-FDF39C2A-7A5B-4D98-9AF0-B96C00FBDE26Q30449416-F3F0D968-25D7-46AD-AC72-E6A4433B21D1Q33730581-941B42A1-A168-4514-828D-64F744909AF5Q33809605-C9D4E5CE-050C-40F2-BEA5-0CC9704803CBQ34592879-75935709-39B4-4A54-95CF-5F60CB96B4A5Q35992446-CA05BF58-75D0-4E2D-BAC8-46E7D2F5BFD3Q35992680-5C5953F2-394D-407C-8746-F590668C30F3Q36465836-DA406DC8-F2B6-43A4-965D-DBB06F1EC22DQ36822883-8D65E15C-50BB-4AC7-8032-4903B28A7EC2Q36946008-4D9EF4CE-808C-4473-A6E0-F750129DF33DQ37622884-4FC6381A-1B20-469C-8D33-FBE570CA5E84Q45075812-EBD341C8-A081-4ABD-BC71-AB46FB11E5A1Q51875003-20AC81E2-3F63-4D00-A06A-6F5D6A94D201
P2860
Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1980
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Preservation of androgen secre ...... f metastatic breast carcinoma.
@en
Preservation of androgen secre ...... f metastatic breast carcinoma.
@nl
type
label
Preservation of androgen secre ...... f metastatic breast carcinoma.
@en
Preservation of androgen secre ...... f metastatic breast carcinoma.
@nl
prefLabel
Preservation of androgen secre ...... f metastatic breast carcinoma.
@en
Preservation of androgen secre ...... f metastatic breast carcinoma.
@nl
P2093
P2860
P356
P1476
Preservation of androgen secre ...... f metastatic breast carcinoma.
@en
P2093
P2860
P304
P356
10.1172/JCI109705
P407
P577
1980-03-01T00:00:00Z